Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 19 citing articles:

Causal relationship between immune cells and hepatocellular carcinoma: a Mendelian randomisation study
Jingyi Tang, Shengke Zhang, Lai Jiang, et al.
Journal of Cancer (2024) Vol. 15, Iss. 13, pp. 4219-4231
Open Access | Times Cited: 12
Exploring the influence of age on the causes of death in advanced nasopharyngeal carcinoma patients undergoing chemoradiotherapy using machine learning methods
Mengni Zhang, Shipeng Zhang, Xudong Ao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Reversing NK cell exhaustion: a novel strategy combining immune checkpoint blockade with drug sensitivity enhancement in the treatment of hepatocellular carcinoma
Yuxiang Huang, Hengjian Liao, Jiefu Luo, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Dual Functional Radioactive Gel‐Microspheres for Combinatorial Radioembolization and Photothermal Therapy of Hepatocellular Carcinoma
Jing Sun, Xingwei Sun, Liang Yin, et al.
Advanced Healthcare Materials (2025)
Open Access
Application of machine learning models to explore prognosis and cause of death in advanced intrahepatic cholangiocarcinoma patients undergoing chemotherapy
Qin Zeng, Xin Wang, Jun Liu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma
Lanqian Su, Huanyu Luo, Yalan Yan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Survival analysis of palliative radiotherapy in patients with HER-2+ metastatic breast cancer
Xueting Li, Xiaorong Zhong, Hongyu Xu, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 2
A dynamic study of VEGF-A siDOX-EVs trafficking through the in-vitro insert co-culture blood-brain barrier model by digital holographic microscopy
Parisa Shamshiripour, Mehrana Rahnama, Mehdi Nikoobakht, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Elucidating the multifaceted role of MGAT1 in hepatocellular carcinoma: integrative single-cell and spatial transcriptomics reveal novel therapeutic insights
Yang Li, Yuan Chen, Danqiong Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Using machine learning methods to investigate the impact of age on the causes of death in patients with early intrahepatic cholangiocarcinoma who underwent surgery
Shiqin Song, Shixiong Song, Huarong Zhao, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 1
Construction of an interpretable model for predicting survival outcomes in patients with middle to advanced hepatocellular carcinoma (≥5 cm) using lasso-cox regression
Han Li, Bo Yang, Chenjie Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Comprehensive analysis of disulfidptosis-related lncRNA features for prognosis and immune landscape prediction in colorectal cancer
Chengyuan Dong, Yadong Guo, Ping Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Postoperative adjuvant immunotherapy for high-risk hepatocellular carcinoma patients
W. Zhang, Qiao Zhang, Li Tan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Macroscopic Characterization of Hepatocellular Carcinoma: An Underexploited Source of Prognostic Factors
Stéphanie Gonvers, Sebastiao N. Martins‐Filho, André Luís da Silva Hirayama, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 707-719
Open Access
Postoperative adjuvant immunotherapy and molecular targeted therapy for patients of hepatocellular carcinoma with portal vein tumor thrombus after hepatectomy: a propensity score matching study
Jiangmin Zhou, Huifang Xiong, Zhiwei Zhang, et al.
Frontiers in Surgery (2024) Vol. 11
Open Access
Role and therapeutic potential of E3s in the tumor microenvironment of hepatocellular carcinoma
Hailin Wang, Qiang Li, Qinqin Tang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Integrating multi-omics techniques and in vitro experiments reveals that GLRX3 regulates the immune microenvironment and promotes hepatocellular carcinoma cell proliferation and invasion through iron metabolism pathways
Yang Li, Yuan Chen, Yang Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancer
Gaofeng Qin, Zengkuan Chen, Weihong Tian, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Advances in external beam radiation for hepatocellular carcinoma, stereotactic body radiation therapy (SBRT) and particle therapy
L Seth, Kevin L. Stephans
Hepatoma Research (2024)
Open Access
Current Treatment Methods in Hepatocellular Carcinoma
Katherine Krupa, Marta Fudalej, Anna Cencelewicz-Lesikow, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4059-4059
Open Access
Page 1

Scroll to top